Penumbra spikes after Stryker- Inari deal
Penumbra (PEN) stock rises as Stryker (SYK) agrees to acquire its rival in the thrombectomy market, Inari Medical (NARI) for $4.9B in cash. Read more here.
Meet the Monster Stock That Continues to Crush the Market
Combined with its diverse product portfolio, that success translates into decent growth potential with a modest risk of collapsing sales during any downturn. Investors might want to keep this stock on ...